Basin, Michael F.
Miguel, Carla M.
Jacob, Joseph M.
Goldberg, Hanan
Grivas, Petros
Spiess, Philippe E.
Necchi, Andrea
Kamat, Ashish M.
Pavlick, Dean C.
Huang, Richard S. P.
Lin, Douglas I.
Danziger, Natalie
Sokol, Ethan S.
Sivakumar, Smruthy
Graf, Ryon
Cheng, Liang
Vasan, Neil
Ross, Jeffrey
Basnet, Alina
Bratslavsky, Gennady
Article History
Accepted: 3 September 2024
First Online: 5 October 2024
Declarations
:
: No external funding was used in the preparation of this manuscript.
: Grivas: Consulting: Aadi Bioscience; AstraZeneca; Asieris Pharmaceuticals, Astellas Pharma, Bristol-Myers Squibb, Boston Gene, CG Oncology, Dyania Health, Lucence Health, Fresenius Kabi, G1 Therapeutics, Gilead, Guardant Health, ImmunityBio, Janssen, Merck KGaA, MSD, Pfizer, PureTech, Roche, SeaGen, Strata Oncology, Silverback Therapeutics. Research funding to institution: Acrivon Therapeutics; ALX Oncology, Bavarian Nordic; Bristol-Myers Squibb; Clovis Oncology; Debiopharm; Merck KGaA; Gilead; Pfizer; MSD; QED Therapeutics; GlaxoSmithKline; G1 Therapeutics; Mirati Therapeutics. Vasan: Consulting and advisory board activities from Magnet Biomedicine, Novartis, and Reactive Biosciences; grants from Gilead outside the submitted work; and a patent for US20210189503A1 pending to Memorial Sloan Kettering Cancer Center. Pavlick, Huang, Lin, Danziger, Sokol, Sivakumar, Graf, Ross: employed by Foundation Medicine, Inc. Basin, Miguel, Jacob, Goldberg, Spiess, Necchi, Kamat, Cheng, Basnet, and Bratslavsky declare that they have no conflicts of interest that might be relevant to the contents of this manuscript. Petros Grivas is an Editorial Board member of Targeted Oncology. Petros Grivas was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: Western Institutional Review Board (Protocol No. 20152817).
: Not applicable.
: Not applicable.
: Available in repository.
: Michael F. Basin: analysis and interpretation of data, manuscript writing; Carla M. Miguel: analysis and interpretation of data, manuscript writing; Joseph M. Jacob: analysis and interpretation of data, critical manuscript review; Hanan Goldberg: critical manuscript review; Petros Grivas: critical manuscript review; Philippe E. Spiess: critical manuscript review; Andrea Necchi: critical manuscript review; Ashish M. Kamat: critical manuscript review; Dean C. Pavlick: acquisition, analysis, critical manuscript review; Richard S.P. Huang: critical manuscript review, Douglas I. Lin: critical manuscript review; Natalie Danziger: acquisition, analysis, critical manuscript review; Ethan S. Sokol: critical manuscript review; Smruthy Sivakumar: critical manuscript review; Ryon Graf: critical manuscript review; Liang Cheng: critical manuscript review; Neil Vasan: critical manuscript review; Jeffrey Ross: conception and design of work, analysis, interpretation, critical manuscript review; Alina Basnet: critical manuscript review; Gennady Bratslavsky: conception and design of work, analysis, interpretation, critical manuscript review.